Clinical trial Recruiting at 1 site Observational

Creating a tool to help patients choose treatments for coronary artery disease

Official title: Mixed Methods Co-design and Evaluation of a DECIsion Support Tool to Enable Shared DEcision Making With People Who Are Considering Revascularisation Options for Coronary Artery Disease

Run by University of Leicester · NCT06567626 · Data updated 2026-11-12

This study is trying to create a helpful tool that guides patients with coronary artery disease in choosing between different treatment options like PCI and CABG based on their personal preferences.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
SexAll
Enrollment126 (estimated)
SponsorUniversity of Leicester
Academic / other
Locations2 sites (Leicester and 1 other locations)
StatusRecruiting
StartedOctober 11, 2024
Main results expectedMarch 2027
Study endsSeptember 2027
Registry record updatedApril 3, 2025
Trial IDNCT06567626 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have experienced coronary revascularization and can provide informed consent.

Probably not a fit

Patients who are unable to provide informed consent or do not speak English may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop a Decision Support Tool (DST) that assists patients with coronary artery disease in understanding their treatment options, specifically comparing percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). By collaborating with patients and healthcare professionals, the study seeks to ensure that the tool reflects individual preferences and values in treatment decisions. The approach involves co-designing the DST through workshops and focus groups, gathering insights from both patients who have experienced revascularization and healthcare providers involved in decision-making. The goal is to empower patients with information that aids in making informed choices about their care.

Why it matters

Potential benefit: If successful, this tool could enhance patient engagement and satisfaction by aligning treatment choices with individual preferences.

How similar studies have gone: Other studies have shown success in using decision support tools to improve patient outcomes in various medical conditions, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
WP1. DST CO-DESIGN PATIENT PARTICIPANTS

Inclusion Criteria

Participants may enter the study if ALL of the following applies:

1. Any adult (≥ 18 years) with lived experience of coronary revascularisation
2. Willing and able to consent to study participation.
3. Able to understand written and spoken English for decisional needs workshop or focus groups (NB this criterion is not required for cognitive interviews or acceptability questionnaire)

Exclusion Criteria

Participants may not enter the study if they are unable to provide informed consent. Individuals who participate in focus groups are ineligible for subsequent participation in cognitive interviews and acceptability questionnaires.

WP1. DST CO-DESIGN HCP PARTICIPANTS

Inclusion Criteria

Participants may enter the study if ALL of the following applies:

1. Healthcare professional with a patient-facing clinical role which involves decision making regarding coronary revascularisation
2. Willing and able to consent to study participation.
3. Able to understand written and spoken English

Exclusion Criteria

Participants may not enter the study if they are unable to provide informed consent.

WP2. DST FEASIBILITY PATIENT PARTICIPANTS

Inclusion Criteria

Participants may enter the study if ALL of the following applies:

1. Adult (≥ 18 years) awaiting coronary revascularisation
2. Has received coronary angiography for definitive diagnosis.
3. Willing and able to consent to study participation.
4. Able to understand written and spoken English, Polish, Romanian, Urdu, Panjabi, or Gujarati

Exclusion Criteria

Participants may not enter the trial if ANY of the following apply:

1. Where clinical consensus strongly recommends one option of revascularisation over another
2. Unable to provide informed consent
3. Unable to speak one of the aforementioned 6 languages

WP2. DST FEASIBILITY HCP PARTICIPANTS

Inclusion Criteria

Participants may enter the study if ALL of the following applies:

1. Healthcare professional with a patient-facing clinical role which involves decision making regarding coronary revascularisation
2. Willing and able to consent to study participation.
3. Able to understand written and spoken English

Exclusion Criteria

Participants may not enter the study if they are unable to provide informed consent.

Where it's running

  • University Hospitals of Leicester
    Leicester, United Kingdom
    Recruiting
  • University of Leicester
    Leicester, United Kingdom
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.